This website is intended for healthcare professionals only

NICE Technology Appraisal 392: Adalimumab for treating moderate to severe hidradenitis suppurativa

Disclaimer: Information intended for healthcare professionals only. The production and printing of this Guidelines Technology Appraisal Card has been funded by AbbVie Ltd. AbbVie Ltd has reviewed this card for technical accuracy and regulatory compliance.

Visit our NEW site!

Guidelines for Nurses provides current, credible summaries and feature articles developed especially for nurses.